Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 vs Lactulose for Minimal Hepatic Encephalopathy in Chronic Liver Disease
NCT01008293Phase 3Completed
- Sponsor
- CD Pharma Group
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 3 trial of VSL#3 in hepatic encephalopathy (HE), sponsored by CD Pharma Group. Started Oct 2009; status: completed.
02
Drugs
VSL#3
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01008293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008293.